Novartis’ gene therapy approved in Europe, talks ongoing on price
The most expensive therapy in the world receives conditional approval in Europe.
The most expensive therapy in the world receives conditional approval in Europe.
WuXi Biologics signs land deal for a clinical and commercial facility located in Massachusetts.